medigraphic.com
ISSN 0035-0052 (Impreso)

2011, Número 5

<< Anterior Siguiente >>

Rev Mex Pediatr 2011; 78 (5)


Utilidad de la procalcitonina en niños con infección sistémica (segunda de dos partes)

Valdez CR, Huerta RJF

Idioma: Español
Referencias bibliográficas: 45
Paginas: 185-191
Archivo PDF: 66.87 Kb.


FRAGMENTO

En la primera parte de esta revisión se mencionó que al comparar los resultados de la medición con la procalcitonina (PCT) con respecto a la prueba semicuantitativa de PCT-Q, los autores encontraron mediciones mayores de 0.5 ng/mL de PCT que fueron calificadas correctamente al estar de acuerdo con los resultados obtenidos con el test rápido semicuantitativo PCT-Q: con sólo tres casos de falsos positivos/dudosos, en los niños con cistitis.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Bamonde RL, Caamaño SB, Alonso MMR. La procalcitonina como marcador de infección. Una revisión desde atención primaria. Rev Pediatr Aten Primaria 2002; 16(4): 619-30.

  2. Acquarolo A, Faletti A, Colombrita D, Tosca D, Bassani L. Procalcitonina e proteina C reattiva in traumatizzati gravi: nuovi e vecchi indicatori di risposta sistemica alle infezioni. BLM 2003; 9(1): 12-17.

  3. Reith HB, Mittelkötter U, Debus ES, Küssner C, Thiede A. Procalcitonin in early detection of postoperative complications. Dig Surg 1998; 15: 260-5.

  4. Aouifi A, Piriou V, Blanc P, Bouvier H, Bastein O, Chiari P et al. Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations. Br J Anaesth 1999; 83(4): 602-7.

  5. Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR et al. Procalcitonin guidance of antibiotic therapy in community acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006; 174: 84-93.

  6. Svoboda P, Kantorova I, Scheer P, Radvanova J, Radvan M. Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery? Hepato-Gastroenterology 2007; 54: 359-63.

  7. Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schüttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998; 24: 680-4.

  8. Mimoz O, Benoist JF, Edouard AR, Assicot M, Bohuon C, Samii K. Procalcitonin and C-reactive protein during the early postraumatic systemic inflammatory response syndrome. Intensive Care Med 1998; 24: 185-8.

  9. Hammer S, Frauberger P, Meiser B, Stangl M, Seidel D, Hammer C. Procalcitonin, a new indicator for non-viral infections in heart, lung or liver transplant patients. Ann Tranplant 1999; 4(2): 5-9.

  10. Beovic B, Kreft S, Osredkar J, Kese D, Bonac-Tuma B. Serum procalcitonin levels in patients with mild community-acquired pneumonia. Clin Microbiol Infect 2005; 11: 1050-1.

  11. Korppi M, Remes S. Serum procalcitonin in pneumococcal pneumonia in children. Eur Respir J 2001; 17: 623-7.

  12. Zarka V, Valat C, Lemarié E, Boissinot E, Carré P, Besnard JC, et al. Serum procalcitonin and respiratory tract infections. Rev Pneumol Clin 1999; 55: 365-9.

  13. Toikka P, Irjala K, Juvén T, Virkki R, Mertsola J, Leinonen M et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 2000; 19: 598-602.

  14. Moulin F, Raymond J, Lorrot R, Marc E, Coste J, Iniguez JL et al. Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch Dis Child 2001; 84: 332-6.

  15. Ebell M. Procalcitonin-guided treatment of respiratory tract infections. Am Fam Physician 2008; 78: 756-7.

  16. García-Zarza M, Ramos AJT, Rubio GE, Corrales del Río E, Zeballos SG, Herrera MJ. Utilidad de la procalcitonina sérica en la orientación etiológica de los niños con neumonía adquirida en la comunidad. An Pediatr (Barc) 2004; 60(3): 279-81.

  17. Fleischhack G, Kambeck I, Cipic D, Hasan C, Bode C. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II. Br J Haematol 2000; 111: 1093-102.

  18. Martínez AM, Pérez MJJ, Gallegos CS, Sánchez ZF, Del Toro AS, Troyo SR et al. Procalcitonin and C-Reactive protein serum levels as markers of infection in a pediatric population with febrile neutropenia and cancer. Pediatr Hematol Oncol 2009; 26: 414–25.

  19. Semeraro M, Thomée C, Rolland C, Le Deley MC, Rosselini D, Troalen F et al. A predictor of unfavourable outcome in neutropenic paediatric patients presenting with fever of unknown origin. Pediatr Blood Cancer 2010; 54: 284-90.

  20. Rau B, Steinbach G, Gansauge F, Mayer JM, Grunert A, Beger HG. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997; 41: 832-40.

  21. Alarcón OC, Ávila BML, Tajmuch V. Pancreatitis aguda. Rev Chil Pediatr 2008; 79(5): 516-21.

  22. Martínez J, Pérez-Mateo M. Evaluación de la gravedad en pancratitis aguda. Rev Mex Gastro 2004; 69(3): 133-37.

  23. Magny JF, Rigourd V, Mitanchez D, Kieffer F, Voyer M. Marqueurs biologiques de l’infection néonatale. J Pédiatr Puériculture 2000 ; 13(Suppl 1): 29-34.

  24. Guibourdenche J, Bedu A, Petzold L, Marchand M, Mariani KP, Marie F et al. Biochemical markers of neonatal sepsis: Value of procalcitonin in the emergency setting. Ann Clin Biochem 2002; 39: 130-5.

  25. Chiesa C, Panero A, Rossi N, Stegagno M, De Giusti M, Osborn JF et al. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis 1998; 26: 664-72.

  26. Chiesa C, Pacífico I, Rossi N, Panero A, Matrunota M, Mancuso G. Procalcitonin as a marker of nosocomial infections in the neonatal intensive care unit. Intensive Care Medicine 2000; 26: S175-7.

  27. Gendrel D, Assicot M, Raymond J, Moulin F, Francoual C, Badoual J et al. Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr 1996; 128: 570-3.

  28. Resch B, Gusenleitner W, Muller WD. Procalcitonin and interleukin-6 in the diagnosis of early-onset sepsis of the neonate. Acta Paediatr 2003; 92: 243-5.

  29. Lapillonne A, Basson E, Monneret G, Bienvenu J, Salle BL. Lack of specificity of procalcitonin for sepsis diagnosis in premature infants. Lancet 1998; 351: 1211-2.

  30. Chiesa C, Pellegrini G, Panero A, Osborn JF, Signore F, Assumma M et al. C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: Influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem 2003; 49: 60-8.

  31. Maire F, Héraud MC, Loriette Y, Normand B, Bègue RJ, Labbé A. Intérêt de la procalcitonine dans les infections néonatales. Arch Pediatr 1999; 6: 503-9.

  32. Monneret G, Labaune JM, Isaac C, Bienvenu F, Putet G. Procalcitonin and C-reactive protein levels in neonatal infections. Acta Paediatr 1997; 86: 209-12.

  33. Enguix A, Rey C, Concha A, Medina A, Coto D, Diéguez MA. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med 2001; 27: 211-5.

  34. Pérez SD, López SJ, Coto CG, Diéguez JM, Deschamps MEM, Crespo HM. Procalcitonina para el diagnóstico de sepsis neonatal de origen nosocomial. An Pediatr (Barc) 2006; 64(4): 349-53.

  35. Spada S, Cuccu A, Mussap M, Pussu M, Pisu C, Burrai P et al. Reliability of procalcitonin in neonatology. Experience in 59 preterm newborns. J Matern-Fetal Neonatal Med 2009; 22(Suppl 3): 96-101.

  36. Mokart D, Merlin M, Sannini A, Brun J, Delpero J. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth 2005; 94: 767-73.

  37. Tang H, Huang T, Jing J, Shen H, Cui W. Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis. Infection 2009; 37: 497-507.

  38. Selberg O, Hecker H, Martin M, Klos A, Bautsch W, Köhl J. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 2000; 28: 2793-8.

  39. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001; 164: 396-402.

  40. Urbach J, Lebenthal Y, Levy S, Berliner S, Leibovtz E, Aronson M et al. Leukocyte adhesiveness/aggregation test (LAAT) to discriminate between viral and bacterial infection in children. Acta Paediatr 2000; 89: 519-22.

  41. Couderc R, Mary R, Veinberg F. Marcadores de inflamación en pediatría. Acta Bioquím Clín Latinoam 2004; 38(4): 513-7.

  42. Philip A, Mills PC. Use of PCR in minimizing antibiotic exposure: experience with infants initially admitted to a well baby nursery. Pediatrics 2000; 106(1): E4.

  43. Torrabadella RP, Pérez MH. La proteína C reactiva en los tiempos de la medicina molecular. Med Clin (Barc) 2005; 125: 775-7.

  44. Morales MG, Ruiz AM, Aguirre SJ, Elizalde GJJ, Poblano MM, Martínez SJ. Procalcitonina en el diagnóstico temprano de sepsis de origen bacteriano. Rev Asoc Mex Med Crit y Ter Int 2006; 20(2): 57-64.

  45. Julián JA, Palomo RM, Ortiz DM, Pedrosa GAR, Parejo MR, Salcedo MR. Utilidad de la procalcitonina y la proteína C reactiva en el paciente con sepsis en urgencias. Emergencias 2009; 21: 23-27.




2020     |     www.medigraphic.com